Roger Hardy Buys 25,000 Shares of Kits Eyecare (TSE:KITS) Stock

Key Points

• Director Roger Hardy bought 25,000 shares of Kits Eyecare at an average price of C$11.37, bringing his direct ownership to 4,093,727 shares and lifting his stake by 0.61%.
• Kits Eyecare shares rose to C$12.15 in Monday trading, while the stock has ranged from C$11.12 to C$22.56 over the past 52 weeks and carries a market cap of about C$412.98 million.
• Analysts remain broadly positive, with four Buy ratings and a consensus price target of C$20.69, even as several firms trimmed their targets after the company’s latest earnings report.

Kits Eyecare Ltd (TSE:KITS - Get Free Report) Director Roger Hardy purchased 25,000 shares of Kits Eyecare stock in a transaction dated Thursday, May 7th. The stock was bought at an average cost of C$11.37 per share, with a total value of C$284,250.00. Following the completion of the transaction, the director directly owned 4,093,727 shares of the company's stock, valued at C$46,545,675.99. This represents a 0.61% increase in their ownership of the stock.

Roger Hardy also recently made the following trade(s):

• On Thursday, May 7th, Roger Hardy acquired 10,000 shares of Kits Eyecare stock. The shares were bought at an average cost of C$11.36 per share, for a total transaction of C$113,600.00.

Kits Eyecare Stock Performance

Kits Eyecare stock traded up C$0.45 during trading hours on Monday, hitting C$12.15. The company had a trading volume of 76,486 shares, compared to its average volume of 116,650. Kits Eyecare Ltd has a fifty-two week low of C$11.12 and a fifty-two week high of C$22.56. The firm has a market cap of C$412.98 million, a PE ratio of 135.00 and a beta of 0.46.

Kits Eyecare (TSE:KITS - Get Free Report) last posted its quarterly earnings results on Wednesday, May 6th. The company reported C$0.06 EPS for the quarter. The company had revenue of C$57.47 million for the quarter.

Wall Street Analyst Weigh In

Several equities research analysts recently commented on the company. Canaccord Genuity Group lowered their price target on Kits Eyecare from C$23.00 to C$22.00 and set a "buy" rating for the company in a research note on Thursday. ATB Cormark Capital Markets reduced their target price on shares of Kits Eyecare from C$20.00 to C$16.75 and set a "speculative buy" rating for the company in a research note on Thursday. Stifel Nicolaus dropped their price target on shares of Kits Eyecare from C$24.00 to C$21.00 and set a "buy" rating on the stock in a research note on Thursday. Finally, Desjardins cut their price target on shares of Kits Eyecare from C$25.00 to C$23.00 and set a "buy" rating on the stock in a report on Thursday. Four equities research analysts have rated the stock with a Buy rating, Based on data from MarketBeat.com, the company currently has a consensus rating of "Buy" and an average price target of C$20.69.

Kits Eyecare Company Profile

KITS TSX: KITS is one of the world's fastest growing eyecare providers, offering high-quality, affordable prescription glasses and contact lenses through its vertically integrated digital platform. With advanced in-house lens manufacturing, an industry-leading digital fit experience powered by OpticianAI, and thousands of 5-star customer reviews, KITS is redefining how Canadians experience eyecare. Designed in Canada. Delivered worldwide.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.